Abstract |
Specific radioimmunoassays, sensitive to plasma levels of less than 1% of normal, were developed for protein C and Factor X. In 31 normal subjects, mean plasma antigen levels were as follows: protein C, 3.23 +/- 0.79 microgram/mL (2 SD); Factor X, 7.74 +/- 1.81 microgram/mL. In patient son chronic warfarin therapy, protein C and factor X were depressed equivalently: protein C, 42% +/- 20% (of a pooled plasma reference); Factor X, 44% +/- 24%. Protein C antigen fell much more rapidly than Factor X antigen when warfarin therapy was begun, creating an initial period of potential hypercoagulability. In patients with severe liver disease, mean protein C antigen (25% +/- 17%) was lower than Factor X antigen (51% +/- 29%). Protein C antigen levels did not appear to be a sensitive indicator of compensated intravascular coagulation or systemic fibrinolysis induced by infusion of streptokinase. Clinical implications of these findings are discussed.
|
Authors | D J Epstein, P W Bergum, S P Bajaj, S I Rapaport |
Journal | American journal of clinical pathology
(Am J Clin Pathol)
Vol. 82
Issue 5
Pg. 573-81
(Nov 1984)
ISSN: 0002-9173 [Print] England |
PMID | 6548600
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Blood Coagulation Factors
- Glycoproteins
- Protein C
- Warfarin
- Factor X
- Streptokinase
|
Topics |
- Blood Coagulation Factors
(analysis)
- Cross Reactions
- Disseminated Intravascular Coagulation
(immunology)
- Factor X
(analysis)
- Female
- Glycoproteins
(analysis)
- Hematologic Diseases
(immunology)
- Hemostasis
- Humans
- Kinetics
- Liver Diseases
(immunology)
- Lupus Erythematosus, Systemic
(immunology)
- Pregnancy
- Protein C
- Radioimmunoassay
- Streptokinase
(pharmacology)
- Warfarin
(pharmacology)
|